Fermata Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Fermata Advisors's LLY Position: Q3 2026 in Review
Fermata Advisors increased its Eli Lilly (LLY) stake by 13% in Q3 2026, buying an estimated $77.9K and bringing the position to 590 shares worth $683K. The position accounts for 0.13% of the portfolio, ranked #142.
Fermata Advisors first reported a position in LLY in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.12M in Q3 2024. 1,048 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Fermata Advisors held 590 shares of Eli Lilly worth $683K as of Q3 2026.
- Fermata Advisors bought 66 Eli Lilly shares in Q3 2026, an estimated $77.9K.
- Eli Lilly made up 0.13% of Fermata Advisors's portfolio in Q3 2026, its #142 holding.
- Fermata Advisors first reported a position in Eli Lilly in Q2 2021 and has held it in 20 quarters since.
- Fermata Advisors's Eli Lilly position peaked at $1.12M in Q3 2024.
- 1,048 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Fermata Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.